KISS1 and uterine corpus leiomyoma: Using kisspeptin antagonists as contraceptives in female patients or therapeutically in sex-steroid-dependent pathologies, such as breast cancer, endometriosis, uterine fibroid, or prostate cancer, represents an essential subject to be investigated [37].